Are E-cigarettes a safe and good alternative to cigarette smoking?

Annals of the New York Academy of Sciences

Volumn 1340, Issue 1, 2015, Pages 65-74

  Rom, Oren ^a   Pecorelli, Alessandra ^b   Valacchi, Giuseppe ^c   Reznick, Abraham Z ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

Cigarette smoking; Electronic cigarette; Nicotine; Smoking cessation

Indexed keywords

ELECTRONIC CIGARETTE; NICOTINE;

ARTICLE; AWARENESS; HEALTH HAZARD; RISK ASSESSMENT; SMOKING; SMOKING CESSATION; SMOKING REGULATION; TOBACCO DEPENDENCE; ADVERSE EFFECTS; HUMAN; PROCEDURES; RISK FACTOR; STANDARDS; TOBACCO USE DISORDER; TRENDS;

NICOTIANA TABACUM;

ELECTRONIC CIGARETTES; HUMANS; RISK FACTORS; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 84926202561     PISSN: 00778923     EISSN: 17496632     Source Type: Journal    
DOI: 10.1111/nyas.12609     Document Type: Article

References (46)

1. The WHO tobacco free initiative, Geneva, Switzerland. Cited July 14, 2014. http://www.who.int/tobacco/mpower/tobacco_facts/en/.
2. Benowitz, N.L. 2010. Nicotine addiction. N. Engl. J. Med. 362: 2295-2303.
3. O'Connor, R.J. 2012. Non-cigarette tobacco products: what have we learnt and where are we headed? Tob. Control 21: 181-190.
4. The WHO tobacco free initiative, Geneva, Switzerland. Cited July 14, 2014. http://www.who.int/tobacco/communications/statements/eletronic_cigarettes/en/.
5. Gilbert, H.A., inventor Smokeless non-tobacco cigarette. 1965. United States patent 3, 209, 819. April 17, 1963.
6. Schraufnagel, D. et al. 2014. Electronic cigarettes: a position statement of the forum of international respiratory societies. Am. J. Respir. Crit. Care. Med. 190: 611-618
7. Adkison, S.E. et al. 2013. Electronic nicotine delivery systems: international tobacco control four-country survey. Am. J. Prev. Med. 44: 207-215.
8. Fuoco, F.C. et al. 2014. Influential parameters on particle concentration and size distribution in the mainstream of e-cigarettes. Environ. Pollut. 184: 523-529.
9. Schroeder, M.J. & A.C. Hoffman. 2014. Electronic cigarettes and nicotine clinical pharmacology. Tob. Control 23: 30-35.
10. Popova, L. & P.M. Ling. 2013. Alternative tobacco product use and smoking cessation: a national study. Am. J. Public. Health 103: 923-930.
11. Regan A.K. et al. 2013. Electronic nicotine delivery systems: adult use and awareness of the 'e-cigarette' in the USA. Tob. Control 22: 19-23.
12. Zhu, S.H. et al. 2014. Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation. Tob. Control 23: 3-9.
13. Pepper, J.K. et al. 2014. Effects of advertisements on smokers' interest in trying e-cigarettes: the roles of product comparison and visual cues. Tob. Control 23: iii31-iii36.
14. Farsalinos, K.E. & G.V. Stimson. 2014. Is there any legal and scientific basis for classifying electronic cigarettes as medications? Int. J. Drug Policy 25: 340-345.
15. King, B.A. et al. 2014. Trends in awareness and use of electronic cigarettes among U.S. adults, 2010-2013. Nicotine Tob. Res. Epub ahead of print.
16. Gallus, S. et al. 2014. E-cigarette awareness, use, and harm perception in Italy: a National Representative Survey. Nicotine Tob. Res. 16: 1541-1548.
17. Etter, J.F. et al. 2011. Electronic nicotine delivery systems: a research agenda. Tob. Control 20: 243-248.
18. McCarthy, M. 2014. American Medical Association calls for stricter regulation of electronic cigarettes. BMJ 348: g4034.
19. Human, D. 2010. Wise Nicotine. Loestoft, Suffolk: Dennis Barber Ltd.
20. Polosa, R. et al. 2013. A fresh look at tobacco harm reduction: the case for the electronic cigarette. Harm. Reduct. J. 10: 19.
21. Le Houezec, J., A. McNeill & J. Britton. 2011. Tobacco, nicotine and harm reduction. Drug Alcohol Rev. 30: 119-123.
22. Fowles, J., & E. Dybing. 2003. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob. Control 12: 424-430.
23. Lik Hon, inventor Flameless electronic atomizing cigarette. 2006. United States patent 2006/0196518 A1, April 29, 2003.
24. Bullen, C. et al. 2013. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 382: 1629-1637.
25. Bullen, C. et al. 2010. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob. Control 19: 98-103.
26. Vansickel, A. & T. Eissenberg. 2013. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob. Res. 15: 267-270.
27. Nides, M.A. et al. 2014. Nicotine blood levels and short-term smoking reduction with an electronic nicotine delivery system. Am. J. Health Behav. 38: 265-274.
28. Farsalinos, K.E. et al. 2014. Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Sci. Rep. 4: 4133.
29. Harrell, P.T. et al. 2014. Electronic nicotine delivery systems ("E-cigarettes"): review of safety and smoking cessation efficacy. Otolaryngol. Head Neck Surg. 151: 381-393.
30. Vardavas, C.I. et al. 2014. Determinants and prevalence of e-cigarette use throughout the European Union: a secondary analysis of 26 566 youth and adults from 27 countries. Tob. Control doi: 10.1136/tobaccocontrol-2013-051394.
31. Lee, S. et al. 2014. Electronic cigarette use among Korean adolescents: a cross-sectional study of market penetration, dual use, and relationship to quit attempts and former smoking. J Adolesc. Health 54: 684-690.
32. Polosa, R. et al. 2011 Effect of an electronic nicotine delivery device (e-cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health 11: 786.
33. Siegel, M.B., K.L. Tanwar & K.S. Wood. 2011. Electronic cigarettes as a smoking-cessation: tool results from an online survey. Am. J. Prev. Med. 40: 472-475.
34. Caponnetto, P. et al. 2013. Efficiency and safety of an electronic cigarette (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One 8: e66317.
35. Garrison, G.D. & S.E. Dugan. 2009. Varenicline: a first-line treatment option for smoking cessation. Clin. Ther. 31: 463-491.
36. Evaluation of e-cigarettes. Center for Drug Evaluation and Research, Division of Pharmaceutical Analysis. Louis, MO: FDA. Cited August 5, 2014. http://www.fda.gov/downloads/drugs/scienceresearch/ucm173250.pdf.
37. Goniewicz, M.L. et al. 2014. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob. Control 23: 133-139.
38. Lauterbach, J.H. & M. Laugesen 2012. Comparison of toxicant levels in mainstream aerosols generated by Ruyan® electronic nicotine delivery systems (ENDS) and conventional cigarette products. [Poster] SOT, San Francisco, CA, March 10-16, 2012.
39. Williams, M. et al. 2013. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS ONE 8: e57987.
40. Cervellati, F. et al. 2014. Comparative effects between electronic and cigarette smoke in human keratinocytes and epithelial lung cells. Toxicology in Vitro 28: 999-1005.
41. Vardavas, C.I. et al. 2012. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest 141: 1400-1406.
42. Vansickel, A.R. et al. 2010. A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol. Biomarkers Prev. 19: 1945-1953.
43. Van Staden, S.R. et al. 2013. Carboxyhaemoglobin levels, health and lifestyle perceptions in smokers converting from tobacco cigarettes to electronic cigarettes. S. Afr. Med. J. 103: 865-868.
44. Durmowicz, E.L. 2014. The impact of electronic cigarettes on the paediatric population. Tob. Control 23: ii41-ii46.
45. Czogala, J. et al. 2014. Secondhand exposure to vapors from electronic cigarettes. Nicotine Tob. Res. 16: 655-662.
46. Chang, H. 2014. Research gaps related to the environmental impacts of electronic cigarettes. Tob. Control 23: ii54-ii58.